Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to continue to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.


Clinical Trial Description

The HM3 LVAS is intended to provide hemodynamic support in patients with advanced, refractory left ventricular heart failure; either for short term support, such as a bridge to cardiac transplantation (BTT) or myocardial recovery, or as long term support, such as destination therapy (DT). The HM3 is intended for use inside or outside the hospital. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02892955
Study type Interventional
Source St. Jude Medical
Contact Carrie Vooght
Email carrie.vooght@abbott.com
Status Recruiting
Phase N/A
Start date September 2016
Completion date March 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02224755 - MOMENTUM 3 IDE Clinical Study Protocol N/A
Active, not recruiting NCT03022461 - HeartMate 3 CE Mark Study Long Term Follow-up
Active, not recruiting NCT02170363 - HeartMate 3™ CE Mark Clinical Investigation Plan N/A